PL3328396T3 - Formulacje oftalmiczne zawierające kooperatywne kompleksy kwasu hialuronowego o małej i dużej masie cząsteczkowej - Google Patents

Formulacje oftalmiczne zawierające kooperatywne kompleksy kwasu hialuronowego o małej i dużej masie cząsteczkowej

Info

Publication number
PL3328396T3
PL3328396T3 PL16741897T PL16741897T PL3328396T3 PL 3328396 T3 PL3328396 T3 PL 3328396T3 PL 16741897 T PL16741897 T PL 16741897T PL 16741897 T PL16741897 T PL 16741897T PL 3328396 T3 PL3328396 T3 PL 3328396T3
Authority
PL
Poland
Prior art keywords
molecular
low
hyaluronic acid
ophthalmic formulations
weight hyaluronic
Prior art date
Application number
PL16741897T
Other languages
English (en)
Inventor
Mario De Rosa
Chiara Schiraldi
Original Assignee
Altergon S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon S.A. filed Critical Altergon S.A.
Publication of PL3328396T3 publication Critical patent/PL3328396T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16741897T 2015-07-28 2016-07-13 Formulacje oftalmiczne zawierające kooperatywne kompleksy kwasu hialuronowego o małej i dużej masie cząsteczkowej PL3328396T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUB2015A002542A ITUB20152542A1 (it) 2015-07-28 2015-07-28 Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
PCT/EP2016/066639 WO2017016873A1 (en) 2015-07-28 2016-07-13 Ophthalmic formulations comprising cooperative complexes of low- and high-molecular-weight hyaluronic acid
EP16741897.9A EP3328396B1 (en) 2015-07-28 2016-07-13 Ophthalmic formulations comprising cooperative complexes of low- and high-molecular-weight hyaluronic acid

Publications (1)

Publication Number Publication Date
PL3328396T3 true PL3328396T3 (pl) 2022-02-14

Family

ID=54364528

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16741897T PL3328396T3 (pl) 2015-07-28 2016-07-13 Formulacje oftalmiczne zawierające kooperatywne kompleksy kwasu hialuronowego o małej i dużej masie cząsteczkowej

Country Status (11)

Country Link
US (2) US20180221404A1 (pl)
EP (1) EP3328396B1 (pl)
CN (2) CN113616669A (pl)
CA (1) CA2993470C (pl)
ES (1) ES2902834T3 (pl)
HK (1) HK1253944A1 (pl)
HU (1) HUE057662T2 (pl)
IT (1) ITUB20152542A1 (pl)
PL (1) PL3328396T3 (pl)
RU (1) RU2733733C2 (pl)
WO (1) WO2017016873A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20152542A1 (it) 2015-07-28 2017-01-28 Altergon Sa Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
CN108904449A (zh) * 2018-08-20 2018-11-30 广州云雾雾化应用技术研究院(普通合伙) 一种雾态软骨素在制备修复角膜的药物中的应用
CN109924485A (zh) * 2019-03-29 2019-06-25 华熙生物科技股份有限公司 一种含透明质酸的减肥保健食品及其制备方法
IT201900024214A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Sostituti del liquido sinoviale
IT201900024208A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Miscele iniettabili di acido ialuronico per uso in dermoestetica
CN114786594A (zh) 2019-12-18 2022-07-22 波士顿科学国际有限公司 具有抗凝血覆盖物的左心耳闭合装置
CN113908171B (zh) * 2021-09-09 2024-01-30 南京睿远医疗技术有限公司 一种眼用润滑液组合物及其应用
TWI821845B (zh) * 2021-12-29 2023-11-11 永勝光學股份有限公司 應用於眼用鏡片的溶液

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
CN1237978C (zh) * 2002-06-20 2006-01-25 上海卫康光学有限公司 一种润眼液组合物及其应用
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
US20070059276A1 (en) * 2005-09-07 2007-03-15 Amo Regional Holdings Bi-modal hyaluronate
CN101500535A (zh) * 2006-06-28 2009-08-05 诺维信生物聚合物公司 用于化妆品和医学用途的具有几种透明质酸级分的组合物
AR062046A1 (es) * 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
FR2962044B1 (fr) 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1402382B1 (it) * 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
US20130012984A1 (en) * 2011-07-07 2013-01-10 Warsaw Orthopedic, Inc. Surgical instrument for grasping an elongated member
EP2596796B1 (en) * 2011-11-24 2013-11-13 Quimera Ingenieria Biomedica, S.L. Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulphate mixtures
US20140348779A1 (en) * 2012-01-08 2014-11-27 Medicure Technologies Ltd. Ophthalmic composition
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
ITUB20152542A1 (it) 2015-07-28 2017-01-28 Altergon Sa Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare

Also Published As

Publication number Publication date
US11878030B2 (en) 2024-01-23
RU2018102693A (ru) 2019-08-30
CN107921056A (zh) 2018-04-17
CA2993470C (en) 2023-09-19
RU2018102693A3 (pl) 2019-12-09
CA2993470A1 (en) 2017-02-02
RU2733733C2 (ru) 2020-10-06
WO2017016873A1 (en) 2017-02-02
ES2902834T3 (es) 2022-03-30
EP3328396B1 (en) 2021-10-20
US20180221404A1 (en) 2018-08-09
HUE057662T2 (hu) 2022-05-28
ITUB20152542A1 (it) 2017-01-28
EP3328396A1 (en) 2018-06-06
HK1253944A1 (zh) 2019-07-05
CN113616669A (zh) 2021-11-09
US20210386776A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
HK1253944A1 (zh) 包含低-和高-分子量透明質酸的協同複合物的眼科製劑
HK1252512A1 (zh) 向眼部遞送藥劑的方法
PL3722274T3 (pl) Związki semifluorowane
GB201913962D0 (en) Ophthalmic drug compositions
EP3188675A4 (en) Delivery system for cardiac pacing
HK1244689A1 (zh) 水性眼科組合物
EP3234107A4 (en) B cells for in vivo delivery of therapeutic agents
SG11201609254YA (en) Therapeutic placental compositions, methods of making and methods of use
EP3209331C0 (en) EYE SOLUTION
SG11201705138QA (en) Aqueous ophthalmic solution
IL271136A (en) Breast milk pump
GB201421163D0 (en) Formulations of metal complexes
GB2568579B (en) Ophthalmic drug compositions
IL253461A0 (en) Hydrogels for the release of therapeutic compounds
EP3240591A4 (en) Implantable electrolytic diaphragm pumps
RS63736B1 (sr) Rastvor bortezomiba spreman za upotrebu
SI3216451T1 (sl) Oftalmični vodni sestavek
EP3136840A4 (en) Aided delivery of plant treatment agents
MX2016012758A (es) Composicion hiperosmolar de acido hialuronico.
EP3094347A4 (en) Methods for enhancing the delivery of active agents
EP3474836C0 (en) OPHTHALMIC MEDICINE CONTAINING SALBUTAMOL.
PL3297626T3 (pl) Kompozycja oftalmiczna zawierająca kwas liponowy i kwas hialuronowy
EP3362085C0 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH MUCIN
EP3182980A4 (en) Treatment of glycosylation deficiency diseases
HK1248594A1 (zh) 改善視覺的基因療法